Rallybio Corp - Common Stock, par value $0.0001 per share (RLYB) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
RLYB on Nasdaq
Shares outstanding
42,271,962
Price per share
$0.69
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
24,139,358
Total reported value
$16,571,283
% of total 13F portfolios
0%
Share change
-58,820
Value change
-$38,170
Number of holders
43
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Rallybio Corp - Common Stock, par value $0.0001 per share (RLYB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VIKING GLOBAL INVESTORS LP 10% $2,897,379 4,222,969 VIKING GLOBAL INVESTORS LP 31 Dec 2025
FMR LLC 4.3% $441,675 1,766,701 FMR LLC 31 Dec 2024

As of 31 Dec 2025, 43 institutional investors reported holding 24,139,358 shares of Rallybio Corp - Common Stock, par value $0.0001 per share (RLYB). This represents 57% of the company’s total 42,271,962 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Rallybio Corp - Common Stock, par value $0.0001 per share (RLYB) together control 57% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VIKING GLOBAL INVESTORS LP 9.9% 4,194,777 0% 0.01% $2,878,037
JOHNSON & JOHNSON 8.6% 3,636,363 0% 0.45% $2,494,909
5AM Venture Management, LLC 8.6% 3,630,724 0% 0.78% $2,491,040
TPG GP A, LLC 7.2% 3,028,414 0% 0.08% $2,089,606
Pivotal bioVenture Partners Investment Advisor LLC 5.7% 2,404,644 0% 0.64% $1,649,586
FMR LLC 4% 1,694,388 0% 0% $1,162,520
Almitas Capital LLC 3.6% 1,529,653 -0.59% 0.23% $1,049,495
VANGUARD GROUP INC 2.4% 1,016,249 +1.7% 0% $697,147
RENAISSANCE TECHNOLOGIES LLC 2% 835,692 +17% 0% $573,368
Canaan Partners XI LLC 1.1% 450,000 0% 0.23% $308,700
Mariner, LLC 0.96% 404,546 0% 0% $277,559
CITADEL ADVISORS LLC 0.6% 253,842 -42% 0% $174,161
GEODE CAPITAL MANAGEMENT, LLC 0.59% 248,005 +1.2% 0% $170,191
BlackRock, Inc. 0.34% 141,663 0% 0% $97,195
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.24% 100,724 -26% 0% $69,107
XTX Topco Ltd 0.23% 97,313 +65% 0% $66,766
ACADIAN ASSET MANAGEMENT LLC 0.2% 83,480 -7.5% 0% $56,000
STATE STREET CORP 0.15% 62,072 0% 0% $42,588
Rangeley Capital, LLC 0.09% 40,000 -52% 0.02% $27,444
NORTHERN TRUST CORP 0.09% 38,124 0% 0% $26,157
TWO SIGMA INVESTMENTS, LP 0.09% 37,000 +72% 0% $25,386
PRUDENTIAL FINANCIAL INC 0.07% 29,100 -24% 0% $19,966
Virtu Financial LLC 0.06% 27,132 -31% 0% $19,000
HRT FINANCIAL LP 0.05% 21,387 -34% 0% $14,000
OneDigital Investment Advisors LLC 0.05% 20,000 0% 0% $13,722

Institutional Holders of Rallybio Corp - Common Stock, par value $0.0001 per share (RLYB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 24,139,358 $16,571,283 -$38,170 $0.69 43
2025 Q3 28,293,762 $14,121,676 -$1,021,666 $0.50 45
2025 Q2 31,192,738 $10,521,574 -$558,784 $0.34 48
2025 Q1 32,001,262 $20,918,290 -$325,165 $0.65 47
2024 Q4 32,428,353 $31,130,298 -$372,186 $0.96 49
2024 Q3 31,212,752 $36,517,099 -$480,838 $1.17 49
2024 Q2 31,632,749 $42,387,896 +$1,547,544 $1.34 64
2024 Q1 30,198,382 $55,866,389 -$3,948,463 $1.85 59
2023 Q4 31,751,116 $75,885,524 +$1,489,758 $2.39 53
2023 Q3 31,203,619 $105,155,071 -$1,411,692 $3.37 58
2023 Q2 33,260,971 $188,259,076 +$6,505,885 $5.66 57
2023 Q1 32,110,359 $183,344,535 -$1,268,660 $5.71 51
2022 Q4 32,312,322 $212,289,584 +$34,532,833 $6.57 55
2022 Q3 27,791,116 $402,136,609 +$2,162,886 $14.47 50
2022 Q2 27,659,695 $208,831,000 -$776,317 $7.55 44
2022 Q1 27,776,100 $193,896,000 +$124,771 $6.98 47
2021 Q4 26,674,067 $252,852,000 +$1,365,608 $9.54 37
2021 Q3 24,054,356 $419,896,000 +$419,896,000 $17.58 33